A recent clinical trial showed that metformin acts on BC tumor cell proliferation differently, with a positive trend toward inhibiting proliferation only in women with insulin resistance or higher BMI [ 51 ].
← all excerpts
Insulin/IGF Axis in Breast Cancer: Clinical Evidence and Translational Insights.
2
—
—
The sentences
Compared with normal weight women, significant or borderline significant increased risks of BC mortality were only observed for morbidly obese (≥40 kg/m 2 ) women and not for women in other obesity categories [ 38 ].